Nantahala Capital Management - AUTOLUS THERAPEUTICS PLC ownership

AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 69 filers reported holding AUTOLUS THERAPEUTICS PLC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Nantahala Capital Management ownership history of AUTOLUS THERAPEUTICS PLC
ValueSharesWeighting
Q2 2023$10,167,843
-28.2%
4,272,203
-44.5%
0.98%
-9.3%
Q1 2023$14,152,936
-4.3%
7,691,813
-1.2%
1.08%
+13.2%
Q4 2022$14,785,834
+30.7%
7,782,018
+47.2%
0.96%
+30.9%
Q3 2022$11,312,000
-22.3%
5,286,088
+2.8%
0.73%
+0.3%
Q2 2022$14,554,000
-19.7%
5,142,855
+18.3%
0.73%
-9.0%
Q1 2022$18,124,000
-14.4%
4,346,327
+6.6%
0.80%
+7.7%
Q4 2021$21,162,000
+10.0%
4,077,509
+38.8%
0.74%
+22.9%
Q3 2021$19,236,000
+61.5%
2,936,791
+63.7%
0.61%
+79.3%
Q2 2021$11,909,0001,793,5000.34%
Other shareholders
AUTOLUS THERAPEUTICS PLC shareholders Q2 2021
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 3,530,657$23,126,0001.85%
TFG Asset Management GP Ltd 2,500,000$16,375,0001.00%
Nantahala Capital Management 2,936,791$19,236,0000.61%
MYDA Advisors LLC 171,953$1,126,0000.32%
SABBY MANAGEMENT, LLC 300,000$1,965,0000.27%
Regency Capital Management Inc.\DE 57,000$373,0000.26%
Ikarian Capital, LLC 544,819$3,568,0000.25%
Eversept Partners, LP 398,074$2,607,3850.18%
Henry James International Management Inc. 54,047$354,0000.11%
Alphabet Inc. 698,262$4,574,0000.11%
View complete list of AUTOLUS THERAPEUTICS PLC shareholders